Company Filing History:
Years Active: 2024-2025
Title: Amandeep Gakhal: Innovator in Antibody Conjugates
Introduction
Amandeep Gakhal is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. With a total of 2 patents, Gakhal's work focuses on innovative therapeutic solutions.
Latest Patents
Gakhal's latest patents include "Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates." These patents relate to antibodies and antibody conjugates that specifically bind to receptor tyrosine kinase orphan receptor 1 (ROR1) and its isoforms and homologs. The patents also cover pharmaceutical compositions and methods for producing and utilizing these antibodies in therapeutic and diagnostic applications.
Career Highlights
Amandeep Gakhal is currently employed at Sutro Biopharma, Inc., where he continues to advance his research in antibody drug conjugates. His work is pivotal in developing new treatments that leverage the specificity of these antibodies for targeted therapies.
Collaborations
Gakhal collaborates with talented professionals in his field, including coworkers Abigail Yu and Ryan Stafford. Their combined expertise contributes to the innovative projects at Sutro Biopharma, Inc.
Conclusion
Amandeep Gakhal's contributions to the field of antibody conjugates exemplify the importance of innovation in biotechnology. His patents and ongoing research hold promise for future therapeutic advancements.